Redwood Park Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Redwood Park Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.49K	Hold	60	–	–	0.01%	182
2026 Q1	$7.66K	Hold	60	–	–	0.01%	189
2025 Q4	$7.32K	Hold	60	–	–	0.01%	186
2025 Q3	$6.01K	Buy	60 +10	+20%	+$901	﹤0.01%	191
2025 Q2	$4.15K	Buy	50 +14	+39%	+$1.12K	﹤0.01%	203
2025 Q1	$2.92K	Hold	36	–	–	﹤0.01%	226
2024 Q4	$3.24K	Buy	+36	New	+$3.49K	﹤0.01%	223

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Redwood Park Advisors's XBI Position: Q2 2026 in Review

Redwood Park Advisors held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 60 shares worth $9.49K. The position accounts for 0.01% of the portfolio, ranked #182.

Redwood Park Advisors first reported a position in XBI in Q4 2024 and has held it in 7 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Redwood Park Advisors held 60 shares of State Street SPDR S&P Biotech ETF worth $9.49K as of Q2 2026.
Redwood Park Advisors left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of Redwood Park Advisors's portfolio in Q2 2026, its #182 holding.
Redwood Park Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 7 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Redwood Park Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.